To confirm whether CD8+ T cells are responsible for inhibiting tumor progression and enhancing activation of the antitumor immune response in Sema6d-KO mice, we performed MOC2 transplantation with or without anti-CD8 antibody treatment to deplete CD8+ T cells (Figure 3A). This evidence concerns the gene SEMA6D and neoplasm.